Reward responsiveness varies by smoking status in women with a history of major depressive disorder

Neuropsychopharmacology

Volumn 40, Issue 8, 2015, Pages 1940-1946

  Janes, Amy C ^a,b   Pedrelli, Paola ^b,c   Whitton, Alexis E ^a,b   Pechtel, Pia ^a,b   Douglas, Samuel ^a   Martinson, Max A ^c   Huz, Ilana ^c   Fava, Maurizio ^b,c   Pizzagalli, Diego A ^a,b,c   Evins, A Eden ^b,c  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIORAL RESEARCH; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PRIORITY JOURNAL; REWARD; SENSITIVITY ANALYSIS; SMOKING; SOCIAL ADAPTATION; TOBACCO DEPENDENCE; ADOLESCENT; DISCRIMINANT ANALYSIS; LEARNING DISORDERS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; REACTION TIME; STATISTICAL BIAS; YOUNG ADULT;

ADOLESCENT; ADULT; BIAS (EPIDEMIOLOGY); DEPRESSIVE DISORDER, MAJOR; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; LEARNING DISORDERS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REACTION TIME; REWARD; SMOKING; YOUNG ADULT;

EID: 84930820135     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.43     Document Type: Article

References (49)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press: Washington, DC.
2. Andreasen JT, Henningsen K, Bate S, Christiansen S, Wiborg O (2011). Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline. J Psychopharmacol 25: 1134-1141.
3. Barr RS, Pizzagalli DA, Culhane MA, Goff DC, Evins AE (2008). A single dose of nicotine enhances reward responsiveness in nonsmokers: implications for development of dependence. Biol Psychiatry 63: 1061-1065.
4. Beck AT, Steer RA, Ball R, Ranieri W (1996). Comparison of beck depression inventories-IA and II in psychiatric outpatients. J Pers Assess 67: 588-597.
5. Bjornson W, Rand C, Connett JE, Lindgren P, Nides M, Pope F et al (1995). Gender differences in smoking cessation after 3 years in the lung health study. Am J Public Health 85: 223-230.
6. Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P (1998). Major depression and stages of smoking. Arch Gen Psychiatry 55: 161-166.
7. Cook JW, Spring B, McChargue D, Hedeker D (2004). Hedonic capacity, cigarette craving, and diminished positive mood. Nicotine Tob Res 6: 39-47.
8. Dichter GS, Kozink RV, McClernon FJ, Smoski MJ (2012). Remitted major depression is characterized by reward network hyperactivation during reward anticipation and hypoactivation during reward outcomes. J Affect Disord 136: 1126-1134.
9. Diwan A, Castine M, Pomerleau CS, Meador-Woodruff JH, Dalack GW (1998). Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders. Schizophr Res 33: 113-118.
10. Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT (2006). Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev 12: 178-207.
11. Evins AE, Pachas G, Mischoulon D, Urbanoski K, Carlini S, Sousa J et al (2011). A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females. J Clin Psychopharmacol 31: 587-602.
12. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) Biometrics Research, New York State Psychiatric Institute: New York, 2002.
13. Glassman AH, Covey LS, Stetner F, Rivelli S (2001). Smoking cessation and the course of major depression: a follow-up study. Lancet 357: 1929-1932.
14. Glassman AH, Helxer JE, Covey LS, Cottler LB, Stetner F, Tipp JE et al (1990). Smoking, smoking cessation, and major depression. JAMA 264: 1546-1549.
15. Grace AA, Bunney BS (1984). The control of firing pattern in nigral dopamine nurons: burst firing. J Neurosci 4: 2877-2890.
16. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
17. Harrison AA, Gasparini F, Markou A (2002). Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology 150: 56-66.
18. Hautus MJ (1995). Corrections for extreme proportions and their biasing effects on estimated values of d'. Behav Res Methods 27: 46-51.
19. Hayford KE, Patten CA, Rummans TA, Schroeder DR, Offord KP, Croghan IT et al (1999). Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br J Psychiatry 174: 173-178.
20. Hitsman B, Papandonatos GD, McChargue DE, DeMott A, Herrera MJ, Spring B et al (2013). Past major depression and smoking cessation outcome: a systematic review and metaanalysis update. Addiction 108: 294-306.
21. Kenny PJ, Markou A (2006). Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 31: 1203-1211.
22. Kessler RC (2003). Epidemiology of women and depression. J Affect Disord 74: 5-13.
23. Kinnunen T, Doherty K, Militello FS, Garvey AJ (1996). Depression and smoking cessation: Characteristics of depressed smokers and effects of nicotine replacement. J Consult Clin Psychol 64: 791-798.
24. Kolbe LJ, Kann L, Collins JL (1993). Overview of the youth risk surveillance system. Public Health Reports 108: 2-10.
25. Leventhal AM, Waters AJ, Kahler CW, Ray LA, Sussman S (2009). Relations between anhedonia and smoking motivation. Nicotine Tob Res 11: 1047-1054.
26. Levin ED, Rezvani AH, Montoya D, Rose JE, Swartzwelder HS (2003). Adolescent-onset nicotine self-administration modeled in female rats. Psychopharmacology 169: 141-149.
27. Liverant GI, Sloan DM, Pizzagalli DA, Harte CB, Kamholz BW, Rosebrock LE et al (2014). Associations among smoking, anhedonia, and reward learning in depression. Behav Ther 13: 2014.
28. Loas G (1996). Vulnerability to depression: a model centered on anhedonia. J Affect Discord 41: 39-53.
29. Macmillan NA, Creelman CD (1991). Detection Theory: A User's Guide. Cambridge University Press: New York.
30. Markou A, Kosten TR, Koob GF (1998). Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 18: 135-174.
31. Meehl PE (1975). Hedonic capacity: some conjectures. Bull Menninger Clin 39: 295-307.
32. Nestler EJ, Carlezon WA (2006). The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59: 1151-1159.
33. Niaura R, Britt DM, Borrelli B, ShadelWG, Abrams DB, Goldstein MG (1999). History and symptoms of depression among smokers during a self-initiated quit attempt. Nicotine Tob Res 1: 251-257.
34. Nolen-Hoeksema S (1987). Sex differences in unipolar depression: evidence and theory. Psychol Bull 101: 259-282.
35. Pechtel P, Dutra SJ, Goetz EL, Pizzagalli DA (2013). Blunted reward responsiveness in remitted depression. J Psychiatr Res 47: 1864-1869.
36. Perkins KA (2001). Smoking cessation in women: special considerations. CNS Drugs 15: 391-411.
37. Perkins KA, Scott J (2008). Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine Tob Res 10: 1245-1251.
38. Pergadia ML, Der-Avakian A, D'Souza MS, Madden PAF, Heath AC, Shiffman S et al (2014). Association between nicotine withdrawal and reward responsiveness in humans and rats. JAMA Psychiatry 71: 1238-1245.
39. Pizzagalli DA (2014). Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol 10: 393-423.
40. Pizzagalli DA, Evins AE, Schetter EC, Frank MJ, Pajtas PE, Santesso DL et al (2008). Single dose of dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness. Psychopharmacology 196: 221-232.
41. Pizzagalli DA, Jahn AL, O'Shea JP (2005). Toward an objective characterization of an anhedonic phenotype: a signal-detection approach. Biol Psychiatry 57: 319-327.
42. Rice ME, Cragg SJ (2004). Nicotine amplifies reward-related dopamine signals in striatum. Nat Neurosci 7: 583-584.
43. Salin-Pascual RJ, de la Fuente JR, Galicia-Polo L, Drucker-Colin R (1995). Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology 121: 476-479.
44. Scharf D, Shiffman S (2004). Are there gender differences in smoking cessation, whith and without bupropion? Pooled-and meta-analysis of clinical trials of Bupropion SR. Addiction 99: 1462-1469.
45. Schultz W (2001). Reward signaling by dopamine neurons. Neuroscientist 7: 293-302.
46. Schultz W, Dayan P, Montague PR (1997). A neural substrate of prediction and reward. Science 275: 1593-1599.
47. Trosclair A, Dube SR (2010). Smoking among adults reporting lifetime depression, anxiety, anxiety with depression, and major depressive episode, United States, 2005-2006. Addict Behav 35: 438-443.
48. Weissman MM, Bland RC, Canino GJ, Farav-elli C, Greenwald S, Hwu H-G et al (1996). Cross-national epidemiology of major depression and bipolar disorder. JAMA 276: 293-299.
49. Zhang H, Sulzer D (2004). Frequency-dependent modulation of dopamine release by nicotine. Nat Neurosci 7: 581-582.